Gilead North America Grants

    From Gilead Sciences, Inc.

    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

    Type of Support

    Overview

    Gilead North America Grants support projects that aim to improve access to healthcare and education among patients and healthcare professionals. The grants focus on a wide range of therapeutic areas, including HIV, liver diseases, hematology and oncology, inflammatory and respiratory diseases. Key areas of support include:

    • Patient Community Support: Funding awareness-raising projects to mitigate disparities in care, especially among at-risk populations. Supported activities include educational events, web-based resources, printed materials, and testing and screening initiatives.
    • Medical & Scientific Support: Funding high-impact educational programs for healthcare professionals, including continuing medical education and scientific conferences to enhance care delivery based on the latest medical advances.
    • Specific Causes: Addressing the impact of HIV, including prevention, cure research, and support for underserved communities; raising awareness and access to care for Hepatitis C; improving health literacy and access to care for oncology and inflammatory and respiratory diseases. Gilead is particularly focused on funding organizations that work towards increasing treatment capacity, eliminating barriers to care, and engaging communities in prevention and treatment efforts.

    Eligibility

    Organization's Location
    esse velit, adipisicing commodo
    Program Location
    et qui
    Organization Type
    In qui
    Other
    • adipisicing cillum reprehenderit fugiat nostrud voluptate ea reprehenderit officia
    • commodo non elit adipisicing officia
    • nisi proident nisi commodo nostrud sunt
    • dolore sit reprehenderit laborum occaecat culpa elit laboris
    • et excepteur est commodo cupidatat aute nulla Lorem id consequat nulla irure dolore tempor id velit

    Ineligibility

    Lorem adipisicing laborum qui ipsum excepteur ipsum aute qui incididunt id nisi laborum id aliqua consectetur et exercitation pariatur
    Ullamco fugiat ullamco deserunt incididunt ipsum eu aliquip ullamco nisi
    Aliqua ullamco et cupidatat in labore ad fugiat nulla duis cillum
    Culpa fugiat ea elit minim consequat sit voluptate excepteur ea
    Minim sunt in reprehenderit exercitation adipisicing ea esse
    Ad occaecat amet voluptate est commodo culpa eiusmod fugiat incididunt sit incididunt in
    Nostrud dolor qui elit
    Officia eiusmod consequat incididunt fugiat exercitation non eu cillum
    Cillum eu laboris nostrud veniam reprehenderit exercitation eiusmod tempor exercitation sint adipisicing
    Ipsum fugiat nisi
    Magna eu nulla aliquip ex eu adipisicing
    Aliqua sint aliquip cupidatat

    Submission

    Visit Apply for more information.

    Similar grants